We Bring Powerful Leverage to Your Success as an Active Partner We Raised USD 200M from Entrepreneurs, Business Leaders and Family Offices We Invest Early Stage and Support Companies All Along their Growth

 

Trading Ticket lets you trade from anywhere

Trading Ticket develops APIs for seamless retail investing. 

 

The company has already partnered with more than 30 financial publishers such as Benzinga, Marketwatch, Stocktwits, Nasdaq, MotleyFool.

 

In July 2015, the company received seed financing from Peter Thiel's Valar and Citi Ventures.

 

For more info : Trade.it

#MaddyREX : Au coeur de l’accélérateur The Refiners avec Julien Ott, fondateur d'Appaloosa - Maddyness

Inside The Refiners, le nouvel accélérateur à San Francisco.

Julien Ott, fondateur de la startup française Appaloosa, revient sur le début de son aventure au coeur de l'accélérateur The Refiners.

Les Français sont en manque de place (Greenkub) - Business Immo https://t.co/DMcK4FQbp5

REPORTAGE : Greenkub constructeur d'espaces à vivre

Tout savoir sur Greenkub, créateur de studios de jardin clés en main

Reportage sur Greenkub, numéro 1 en Europe de la construction d'extensions de maison et studios de jardin et interview de son PDG Alexandre Gioffredy.

Timeline Photos

4 V-Road de la flotte V-Motech réunis par ses clients pour des missions en altitude.

Latest
investments

September, 2016

Stormize offers a SaaS tools allowing e-merchants to increase their sales by optimizing their merchandising.

 

The tools allows them to modify in real time the showcasing of the products in their stores based on algorithms tracking and processing visitors data such as their browsing pattern.

 

The company is based in Paris.

August, 2016

Happy Meal is an on-demand mobile based healthy Chinese lunch box delivery service targeting China’s college educated professionals.

 

Customers choose between a set of different meals which are delivered to their door, mainly office buildings, within 15 minutes.

 

The company operates in Shanghai.

August, 2016

OCR is a Contract Research Organization (CRO) offering pharmas & biotechs to test their drugs under developement on canine models either before moving to man or getting market approval for animal medication.

 

OCR has a top level multidisciplinary team driven by high ethical and Scientific standards.


Videos (in french)

Guides on
investment (in french)

Growth capital : a practical guide

Download

Exit Solutions from Growth Equity Investments: The Essential Guide

Download

Entrepreneurs & Investors : a practical guide

Download